Sonnenschein Elazar purchased $16K of PLSM (indirect holdings)

Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM) has registered its home ultrasound system, Pulsenmore FC, with the UK's MHRA, allowing it to market the product in the UK and Northern Ireland. The system is designed for women undergoing IVF and fertility preservation treatments, enabling at-home monitoring. The UK fertility market saw over 100,000 treatment cycles in 2024, according to the HFEA. This expansion follows the company's recent European registration under the Medical Device Regulation (MDR

Pulsenmore (NASDAQ: PLSM, TASE: PLSM) has expanded its fertility platform into the UK after completing MHRA registration for its home ultrasound system, Pulsenmore FC. The system allows women undergoing IVF to perform vaginal ultrasound scans at home, reducing clinic visits. The UK market saw over 100,000 fertility treatment cycles in 2024, according to the HFEA.

Pulsenmore Ltd. (PLSM) furnished an SEC Form 6-K — earnings release. Exhibit 99.3 Pulsenmore Ltd. Announces Financial Results and Business Highlights for the First Half of 2026 Management to Host Webcast today at 8:30 am ET to discuss Results and Provide Business Update Omer, Israel –August 31, 2026 – Pulsenmore Ltd. (Nasdaq/TASE: PLSM ), a leadin

Pulsenmore Ltd. (NASDAQ:PLSM) shares jumped about 160% after the company said it was selected for Israel’s Healthcare AI Regulatory Sandbox Program by the Israel Innovation Authority and Ministry of Health. Pulsenmore will receive funding for a $1 million project to develop and clinically validate AI for its home ultrasound platform, with Beilinson Hospital/Clalit Health Services.

GORDON CARL L purchased 472,571 indirectly-held shares of Electra Therapeutics, Inc. (ETRA) at an average of $7.63 ($7.07–$7.88, $3.61M total) across 10 trades over 2026-11-03 to 2026-11-05.

Johnson Timothy Steven (Chief Executive Officer) purchased 90,000 shares of BLACKSTONE MORTGAGE TRUST, INC. (BXMT) at $11.50 ($1.04M total) on 2026-11-04.